Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01819883 · ClinicalTrials.gov registry record
Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 40
- Enrollment target
NCT01819883: Completed study, sponsored by Massachusetts General Hospital.
NCT01819883 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01819883 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This study investigates fat distribution in people with acromegaly. The investigator is also investigating the change of fat distribution before and after treatment of acromegaly. The investigator will compare the results of people with acromegaly to the results of healthy volunteers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-04 |
| Est. Completion | 2016-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01819883
The ClinicalTrials.gov registry entry for NCT01819883 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01819883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01819883 about?
NCT01819883 is a clinical study titled "Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly". This study investigates fat distribution in people with acromegaly. The investigator is also investigating the change of fat distribution before and after treatment of acromegaly. The investigator will compare the results of people with acromegaly to the results of healthy volunteers.
What is the current status of trial NCT01819883?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2013-04. Estimated completion is 2016-03-30.
Who is sponsoring clinical trial NCT01819883?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.